This website is intended exclusively for healthcare professionals residing and/or working in the KSA.

Clopidogrel as the standard of care for elective PCI: Findings from the ALPHEUS

Watch the video and get to know more on ALPHEUS trial. Since Percutaneous coronary intervention (PCI)-related myonecrosis is frequent and can affect the long-term prognosis of patients, then stronger platelet inhibition could potentially lower these events and make the PCI procedure safer.

MAT-BH-2200189/v2/Jun 2023

YOU WILL NOW BE LEAVING THE SITE

By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

Continue

This website is intended exclusively for healthcare professionals residing and/or working in the KSA.

Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.